RT Journal Article
SR Electronic
T1 Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006348
DO 10.1136/jitc-2022-006348
VO 11
IS 5
A1 Demerlé, Clémence
A1 Gorvel, Laurent
A1 Mello, Marielle
A1 Pastor, Sonia
A1 Degos, Clara
A1 Zarubica, Ana
A1 Angelis, Fabien
A1 Fiore, Frédéric
A1 Nunes, Jacques A
A1 Malissen, Bernard
A1 Greillier, Laurent
A1 Guittard, Geoffrey
A1 Luche, Hervé
A1 Barlesi, Fabrice
A1 Olive, Daniel
YR 2023
UL http://jitc.bmj.com/content/11/5/e006348.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.